Takotsubo Syndrome: Does Gender Impact Prognosis?

Takotsubo Syndrome (STT) is characterized by acute cardiac failure which can be reversed in many occasions, but is associated with morbidity and mortality at short and long term. 

Síndrome de Tokotsubo ¿El género tiene influencia en su pronóstico?

It is most frequent among women, especially after menopause. However, gender differences have not been looked into when analyzing the evolution of this cardiomyopathy. 

This was an analysis of the GEIST Registry including 2492 patients with STT. 286 were men (11%).

Men were younger (69 vs. 71, P=0.005), presented more smoking, diabetes, pulmonary disease, and cancer. In addition, they presented more dyspnea and less precordial pain vs. women. 

STT triggering episodes were more physical in men and more emotional in women. 

There were no differences in ECG, but there was in ejection fraction, which was lower in men (38% vs. 40% P=0.001).

Read also: Results of Zotarolimus-Eluting Stents vs Biolimus-Eluting Polymer-Free Stents After 2 Years. Are They Safe in Patients at High Risk for Bleeding?

Men presented more cardiogenic shock (19% vs. 8% P<0.001), inhospital mortality (7% vs. 2% P<0.001) and longer hospital stay.

After propensity score matching 207 pair of patients were left in each group: men had more cardiogenic shock and higher mortality (16% vs 6%, P=0.002 and 8% vs 3%; P=0.003 respectively). 

At long term followup, mortality was 4.3% patient/ years, and was higher in men (10% vs. 3.8% patient /year in the complete series, and 11.5% vs 6.1% patient/year in the matched cohort, respectively). At 60-day followup, mortality was higher in men, but this was not the case in the matched cohort.

Read also: PCI on Native Arteries or Saphenous Vein Grafts: Which Has Better Prognosis?

Multivariable analysis showed that male sex was a predictor of inhospital mortality and mortality at followup. 

Conclusion

Takotsubo syndrome in men involves high risk, and therefore requires more strict control in hospital and after discharge, at long term. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Gender Differences in Takotsubo Syndrome.

Reference: Luca Arcari, J Am Coll Cardiol 2022;79:2085–2093.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....